Overview
The fund invests in equities of major Swiss companies that are included in the SPI.
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
The fund holds all large and mid cap stocks in proportion to the free-float market capitalisation of the reference index. It invests in a selection of small cap stocks from the index according to the criteria of market liquidity and the sector’s free-float market capitalisation.
Diversification is achieved via a mix of sectors and therefore offers the investor an optimised risk/return profile.
The investment objective is to generate a performance in line with that of the benchmark, keeping the Tracking Error below the maximum of 0.5% over a rolling period of 3 years.
Benefits
Easy access to the Swiss stock market.
Optimised risk/return profile thanks to a broad diversification across a range of sectors.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
麻豆社 Equity Funds 麻豆社 Index Funds Equities |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
February 27, 2017
|
| Currency of account |
CHF
|
| Close of financial year |
September 30
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.15% p.a.
|
| Management fee |
0.10% p.a.
|
| Total expense ratio (TER) |
0.15% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SPI® (TR)
|
| Securities no. |
35656911
|
| ISIN |
CH0356569118
|
| Bloomberg Ticker |
UBESPAW SW
|
Performance and Prices
Percentage growth
as of May 27, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 5.48 | 7.28 | 6.20 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 17.60 | 18.61 | 34.52 |
| 3Y | |||
| 5Y | 30.56 | 56.33 | 48.97 |
| ø p.a.5Y | 5.48 | 9.35 | 8.30 |
Current data
| Net asset value | 27.05.2026 | CHF 188.69 |
| High - last 12 months | 27.02.2026 | CHF 189.01 |
| Low - last 12 months | 06.08.2025 | CHF 162.56 |
| Assets of the unit class in mn | 27.05.2026 | CHF 281.40 |
| Total product assets in mn | 27.05.2026 | CHF 4,583.57 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 30.04.2026 | 11.72% | 12.38% |
| Sharpe Ratio | 30.04.2026 | 0.89 | 0.40 |
| Risk Free Rate | 30.04.2026 | 0.40% | 0.41% |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| Roche Holding AG | 13.44 |
| Novartis AG | 13.11 |
| Nestle SA | 11.73 |
| ABB Ltd | 7.13 |
| 麻豆社 Group AG | 6.10 |
| Zurich Insurance Group AG | 4.81 |
| Cie Financiere Richemont SA | 4.60 |
| Holcim AG | 2.23 |
| Swiss Re AG | 2.17 |
| Lonza Group AG | 1.94 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
||
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|